New Head to head Published Apr 5, 2026
Tongkat Ali vs Fadogia agrestis for testosterone, libido, and practical safety
Pick Tongkat Ali if you want the more evidence-based and better standardized option for testosterone and libido support. Skip Fadogia agrestis unless you knowingly accept animal-only efficacy evidence, unclear dosing, and larger safety uncertainty.
Evidence summary
Evidence summary
For evidence-based testosterone and libido support, Tongkat Ali is the better choice; for buyers accepting animal-only evidence and larger safety uncertainty, Fadogia agrestis is the speculative alternative.
- Tongkat Ali raised serum total testosterone in men across clinical trials1, giving the human evidence base a clear edge.
- Fadogia agrestis wins only on preclinical curiosity; human testosterone, libido, and dose data remain absent.
- Tongkat Ali has standardized root extracts and formal safety review; Fadogia agrestis carries greater liver, kidney, and fertility uncertainty.
The verdict
Tongkat Ali wins for most health-conscious buyers. It has human randomized trials, a testosterone meta-analysis, and identifiable extract standards, while Fadogia agrestis relies mainly on rat studies and has unresolved liver and kidney safety signals.13910 The practical choice is not that Tongkat Ali is proven for everyone. It is that Tongkat Ali gives you enough human data to make a cautious, measurable trial, while Fadogia currently asks buyers to accept too much guesswork.
The contenders
Two ways to approach the same goal
Option A
Tongkat Ali (Eurycoma longifolia)
Standardization
Best supported products are standardized root water extracts. Physta is commonly specified at 0.8 to 1.5% eurycomanone, at least 22% total protein, at least 30% polysaccharides, and at least 40% glycosaponins. Eurycomanone is a marker compound used to check whether the extract contains the expected Tongkat Ali chemistry, not proof by itself that the product will work.
Forms
Capsules, tablets, powders, and standardized root water extracts. Human trials most often use standardized extracts rather than raw root powder.
Typical dosage
Common human trial doses are 100 to 400 mg per day of standardized extract, often for 2 to 12 weeks. Some male sexual health trials used 200 to 400 mg per day, including 200 mg daily Physta for 12 weeks in aging men.
Strengths
- Has human clinical evidence for supporting total testosterone, especially in men with low baseline testosterone. A 2022 systematic review included nine studies and meta-analyzed five randomized clinical trials, finding a significant increase in total testosterone compared with control.
- May support sexual well-being and quality-of-life measures in men, based on randomized Tongkat Ali trials using standardized extracts.
- Has clearer product quality markers than Fadogia, because standardized Tongkat Ali extracts can be assayed for eurycomanone, glycosaponins, polysaccharides, and protein.
Trade-offs
- The testosterone evidence is promising rather than settled, because trials are relatively small, vary by extract, and often focus on short periods rather than long-term use.
- Quality varies widely across products, so raw root powder or vague ratio extracts are harder to compare with the doses used in trials.
- European Food Safety Authority reviewers could not establish safety for the proposed novel food use because of concerns from genotoxicity data, meaning they saw enough uncertainty about potential DNA damage signals to avoid a positive safety conclusion.
Safety
Short-term human studies generally report tolerability at studied doses, but long-term safety is not well established. Avoid during pregnancy or breastfeeding, use caution with hormone-sensitive conditions, and consult a clinician if you use medications or have liver, kidney, prostate, fertility, or endocrine concerns.256
Option B
Fadogia agrestis
Standardization
No widely accepted human clinical standardization was found. Products often list stem or whole-plant extract amounts, but there is no trial-validated marker comparable to eurycomanone for Tongkat Ali.
Forms
Capsules and powders marketed as testosterone or libido supplements. Published efficacy evidence is mainly animal research using aqueous stem extract, not standardized commercial human products.
Typical dosage
Unknown for humans. The commonly cited efficacy study used rats, not people, and the toxicity study tested 18, 50, and 100 mg per kg body weight in male rats for 28 days. These animal doses should not be treated as a human dosing guide.
Strengths
- Animal research suggests possible testosterone and sexual behavior effects, but this has not been confirmed in human randomized trials.
- May appeal to buyers seeking a newer libido-oriented botanical, but that appeal is based on early animal data and supplement marketing rather than human outcome data.
Trade-offs
- No convincing human clinical trial evidence was found for testosterone, libido, strength, mood, or fertility outcomes.
- Safety is a major uncertainty. In male rats, Fadogia stem extract changed liver and kidney enzyme patterns and increased malondialdehyde, a marker of oxidative damage to fats in cell membranes.
- Product standardization is weak, so two bottles labeled Fadogia agrestis may not contain comparable chemistry or potency.
Safety
Because human safety data are lacking and rat data raise liver and kidney concerns, Fadogia is a poor fit for conservative buyers, people trying to conceive, people with liver or kidney disease, and anyone taking medications without clinician oversight.10
Head-to-head
How they compare, criterion by criterion
Human evidence for testosterone support
Winner: A · Tongkat Ali (Eurycoma longifolia)Importance: high
Tongkat Ali has a 2022 systematic review with nine studies and five randomized clinical trials in the meta-analysis, showing a significant increase in total testosterone, especially in men with low baseline testosterone.1 Fadogia's testosterone evidence is mainly a male rat study, so it cannot be assumed to work the same way in people.9
Libido and sexual well-being evidence
Winner: A · Tongkat Ali (Eurycoma longifolia)Importance: high
Safety and tolerability confidence
Winner: A · Tongkat Ali (Eurycoma longifolia)Importance: high
Standardization and quality control
Winner: A · Tongkat Ali (Eurycoma longifolia)Importance: high
Dose clarity
Winner: A · Tongkat Ali (Eurycoma longifolia)Importance: high
Bioavailability and formulation evidence
Winner: A · Tongkat Ali (Eurycoma longifolia)Importance: medium
Tongkat Ali has published pharmacokinetic work on eurycomanone, meaning researchers have measured how a key marker behaves in the body after intake.4 Fadogia lacks comparable human absorption and formulation evidence, so buyers cannot tell whether a capsule reliably delivers active compounds to target tissues.
Cost per evidence-backed dose
Winner: A · Tongkat Ali (Eurycoma longifolia)Importance: medium
Conservative health-conscious use
Winner: A · Tongkat Ali (Eurycoma longifolia)Importance: high
Novelty or experimental appeal
Winner: B · Fadogia agrestisImportance: low
Which should you choose
By goal and use case
You want the more evidence-based testosterone support option
You have liver or kidney concerns, or you use multiple medications
Choose Tongkat Ali only with clinician input, and avoid Fadogia. Fadogia has animal signals involving liver and kidney cell membrane stress, which is the wrong uncertainty profile for someone already managing organ or medication risks.10
You are optimizing libido but want to avoid high-risk self-experimentation
You are trying to conceive or actively tracking fertility markers
You only want products with clear label standards
Safety considerations
Do not combine either supplement with hormone therapy, fertility drugs, or medicines affecting mood, blood pressure, liver function, kidney function, or blood sugar without professional guidance. For Tongkat Ali, use products with disclosed standardization and consider limiting any self-directed trial to the time frames studied in humans, often 2 to 12 weeks, unless supervised.123 For Fadogia, the safer buyer decision is avoidance until human dosing and safety studies exist, because the same animal literature used to justify testosterone claims also raises liver and kidney concerns.910 Stop use and seek medical advice if you develop insomnia, agitation, palpitations, abdominal pain, dark urine, yellowing of the skin or eyes, unusual fatigue, or changes in urination.
Frequently asked
Common questions
Can I stack Tongkat Ali and Fadogia together?
Should I get bloodwork before trying Tongkat Ali?
Is a higher eurycomanone percentage always better for Tongkat Ali?
Is Fadogia safer if I cycle it?
Who should avoid both supplements?
Related
Read each variant on its own
Standalone evidence guides and systematic reviews for the supplements being compared here.
Sources
- 1. Eurycoma longifolia (Jack) Improves Serum Total Testosterone in Men: A Systematic Review and Meta-Analysis of Clinical Trials (2022) systematic review and meta-analysis ↑
- 2. Effect of Eurycoma longifolia standardised aqueous root extract Physta on testosterone levels and quality of life in ageing male subjects: a randomised, double-blind, placebo-controlled multicentre study (2021) randomized controlled trial ↑
- 3. Efficacy of Labisia pumila and Eurycoma longifolia standardised extracts on hot flushes, quality of life, hormone and lipid profile of peri-menopausal and menopausal women: a randomised, placebo-controlled study (2020) randomized controlled trial ↑
- 4. Bioavailability of Eurycomanone in Its Pure Form and in a Standardised Eurycoma longifolia Water Extract (2018) pharmacokinetic study ↑
- 5. Safety of Eurycoma longifolia (Tongkat Ali) root extract as a novel food pursuant to Regulation (EU) 2015/2283 (2021) regulatory safety opinion ↑
- 6. Tongkat Ali (2024) NIH LiverTox monograph ↑
- 7. Review on a Traditional Herbal Medicine, Eurycoma longifolia Jack (Tongkat Ali): Its Traditional Uses, Chemistry, Evidence-Based Pharmacology and Toxicology (2016) narrative review ↑
- 8. Randomized Clinical Trial on the Use of PHYSTA Freeze-Dried Water Extract of Eurycoma longifolia for the Improvement of Quality of Life and Sexual Well-Being in Men (2012) randomized clinical trial ↑
- 9. Aphrodisiac potentials of the aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem in male albino rats (2005) animal study ↑
- 10. Mode of cellular toxicity of aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem in male rat liver and kidney (2009) animal toxicity study ↑